News | October 2, 2025
Shalabh Gupta and Amran Nawaz, Associate Directors in Secretariat’s Global Sports Consulting practice, were recently quoted in an S&P Global article discussing sports team acquisition and valuation trends.
May 13, 2024
By Richard Manning and Fred Selck
A new class of anti-obesity medications (AOMs) called GLP-1s have been shown to be highly effective at helping people lose weight. Given the efficacy of GLP-1s, and the significant long-term costs associated with treating obesity and its related diseases, there is increasing pressure on public and private health insurers to cover AOMs. This white paper by Richard Manning and Fred Selck finds that when current state market dynamics and assumptions are included in precise financial analytics, treating obesity does not present the threat to Medicare’s financial solvency that other recently published analyses suggest.
Shalabh Gupta and Amran Nawaz, Associate Directors in Secretariat’s Global Sports Consulting practice, were recently quoted in an S&P Global article discussing sports team acquisition and valuation trends.
Executive Scandals: Navigating Reputational and Financial Risks
Executive Scandals: 2025 Navigating Reputational and Financial Risks, authored by experts from FGS Global and Secretariat, provides a practical framework for boards, legal teams, and compliance professionals. It highlights four core practices including preparation, independent guidance, thorough investigations, and consistent communications that strengthen organizational resilience and protect corporate reputation.
Mid-Year 2025 Update: Nazaha’s Progress in the Fight Against Corruption
As part of its ongoing mandate to enhance transparency and integrity, Saudi Arabia’s Oversight and Anti-Corruption Authority (Nazaha), has continued its efforts. For the six months to June 2025, Nazaha have conducted areas of engagement into new authorities.